Selected research
Market Structure
Global Cinnarizine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cinnarizine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cinnarizine Tablets include Actavis, Bristol Myers Squibb, Glenmark Pharmaceuticals, Johnson & Johnson, McNeil Products, Peak Pharmacy, Sanofi, Teva Pharmaceuticals and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cinnarizine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cinnarizine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cinnarizine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cinnarizine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Cinnarizine Tablets Segment by Company
Actavis
Bristol Myers Squibb
Glenmark Pharmaceuticals
Johnson & Johnson
McNeil Products
Peak Pharmacy
Sanofi
Teva Pharmaceuticals
Torrent Pharmaceuticals
Beijing Neptunus Zhongxin Pharmaceutical
Cisen Pharma
Harbin Pharmaceutical Group
Nanjing Baijingyu Pharmaceutical
Shanghai Xinyi Wanxiang Pharmaceutical
CSPC
Cinnarizine Tablets Segment by Type
15mg per Tablet
25mg per Tablet
Cinnarizine Tablets Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Cinnarizine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cinnarizine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cinnarizine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cinnarizine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cinnarizine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 15mg per Tablet
- 25mg per Tablet
Applications
- Hospital and Clinic
- Retail Pharmacies
- Other
Companies covered
- Actavis
- Bristol Myers Squibb
- Glenmark Pharmaceuticals
- Johnson & Johnson
- McNeil Products
- Peak Pharmacy
- Sanofi
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
- Beijing Neptunus Zhongxin Pharmaceutical
- Cisen Pharma
- Harbin Pharmaceutical Group
- Nanjing Baijingyu Pharmaceutical
- Shanghai Xinyi Wanxiang Pharmaceutical
- CSPC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cinnarizine Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cinnarizine Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cinnarizine Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cinnarizine Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cinnarizine Tablets Market Dynamics
- 2.1 Cinnarizine Tablets Industry Trends
- 2.2 Cinnarizine Tablets Industry Drivers
- 2.3 Cinnarizine Tablets Industry Opportunities and Challenges
- 2.4 Cinnarizine Tablets Industry Restraints
3 Cinnarizine Tablets Market by Manufacturers
- 3.1 Global Cinnarizine Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Cinnarizine Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Cinnarizine Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cinnarizine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cinnarizine Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cinnarizine Tablets Manufacturers, Product Type & Application
- 3.7 Global Cinnarizine Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cinnarizine Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cinnarizine Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Cinnarizine Tablets Tier 1, Tier 2, and Tier 3
4 Cinnarizine Tablets Market by Type
- 4.1 Cinnarizine Tablets Type Introduction
- 4.1.1 15mg per Tablet
- 4.1.2 25mg per Tablet
- 4.2 Global Cinnarizine Tablets Sales by Type
- 4.2.1 Global Cinnarizine Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cinnarizine Tablets Sales by Type (2021-2032)
- 4.2.3 Global Cinnarizine Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Cinnarizine Tablets Revenue by Type
- 4.3.1 Global Cinnarizine Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cinnarizine Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Cinnarizine Tablets Revenue Market Share by Type (2021-2032)
5 Cinnarizine Tablets Market by Application
- 5.1 Cinnarizine Tablets Application Introduction
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Other
- 5.2 Global Cinnarizine Tablets Sales by Application
- 5.2.1 Global Cinnarizine Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cinnarizine Tablets Sales by Application (2021-2032)
- 5.2.3 Global Cinnarizine Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Cinnarizine Tablets Revenue by Application
- 5.3.1 Global Cinnarizine Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cinnarizine Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Cinnarizine Tablets Revenue Market Share by Application (2021-2032)
6 Global Cinnarizine Tablets Sales by Region
- 6.1 Global Cinnarizine Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cinnarizine Tablets Sales by Region (2021-2032)
- 6.2.1 Global Cinnarizine Tablets Sales by Region (2021-2026)
- 6.2.2 Global Cinnarizine Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cinnarizine Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cinnarizine Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cinnarizine Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cinnarizine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cinnarizine Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cinnarizine Tablets Revenue by Region
- 7.1 Global Cinnarizine Tablets Revenue by Region
- 7.1.1 Global Cinnarizine Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cinnarizine Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Cinnarizine Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Cinnarizine Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cinnarizine Tablets Revenue (2021-2032)
- 7.2.2 North America Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cinnarizine Tablets Revenue (2021-2032)
- 7.3.2 Europe Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cinnarizine Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cinnarizine Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cinnarizine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Actavis
- 8.1.1 Actavis Company Information
- 8.1.2 Actavis Business Overview
- 8.1.3 Actavis Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Actavis Cinnarizine Tablets Product Portfolio
- 8.1.5 Actavis Recent Developments
- 8.2 Bristol Myers Squibb
- 8.2.1 Bristol Myers Squibb Company Information
- 8.2.2 Bristol Myers Squibb Business Overview
- 8.2.3 Bristol Myers Squibb Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bristol Myers Squibb Cinnarizine Tablets Product Portfolio
- 8.2.5 Bristol Myers Squibb Recent Developments
- 8.3 Glenmark Pharmaceuticals
- 8.3.1 Glenmark Pharmaceuticals Company Information
- 8.3.2 Glenmark Pharmaceuticals Business Overview
- 8.3.3 Glenmark Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Glenmark Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 8.3.5 Glenmark Pharmaceuticals Recent Developments
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson Company Information
- 8.4.2 Johnson & Johnson Business Overview
- 8.4.3 Johnson & Johnson Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Johnson & Johnson Cinnarizine Tablets Product Portfolio
- 8.4.5 Johnson & Johnson Recent Developments
- 8.5 McNeil Products
- 8.5.1 McNeil Products Company Information
- 8.5.2 McNeil Products Business Overview
- 8.5.3 McNeil Products Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 McNeil Products Cinnarizine Tablets Product Portfolio
- 8.5.5 McNeil Products Recent Developments
- 8.6 Peak Pharmacy
- 8.6.1 Peak Pharmacy Company Information
- 8.6.2 Peak Pharmacy Business Overview
- 8.6.3 Peak Pharmacy Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Peak Pharmacy Cinnarizine Tablets Product Portfolio
- 8.6.5 Peak Pharmacy Recent Developments
- 8.7 Sanofi
- 8.7.1 Sanofi Company Information
- 8.7.2 Sanofi Business Overview
- 8.7.3 Sanofi Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sanofi Cinnarizine Tablets Product Portfolio
- 8.7.5 Sanofi Recent Developments
- 8.8 Teva Pharmaceuticals
- 8.8.1 Teva Pharmaceuticals Company Information
- 8.8.2 Teva Pharmaceuticals Business Overview
- 8.8.3 Teva Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Teva Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 8.8.5 Teva Pharmaceuticals Recent Developments
- 8.9 Torrent Pharmaceuticals
- 8.9.1 Torrent Pharmaceuticals Company Information
- 8.9.2 Torrent Pharmaceuticals Business Overview
- 8.9.3 Torrent Pharmaceuticals Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Torrent Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 8.9.5 Torrent Pharmaceuticals Recent Developments
- 8.10 Beijing Neptunus Zhongxin Pharmaceutical
- 8.10.1 Beijing Neptunus Zhongxin Pharmaceutical Company Information
- 8.10.2 Beijing Neptunus Zhongxin Pharmaceutical Business Overview
- 8.10.3 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Product Portfolio
- 8.10.5 Beijing Neptunus Zhongxin Pharmaceutical Recent Developments
- 8.11 Cisen Pharma
- 8.11.1 Cisen Pharma Company Information
- 8.11.2 Cisen Pharma Business Overview
- 8.11.3 Cisen Pharma Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Cisen Pharma Cinnarizine Tablets Product Portfolio
- 8.11.5 Cisen Pharma Recent Developments
- 8.12 Harbin Pharmaceutical Group
- 8.12.1 Harbin Pharmaceutical Group Company Information
- 8.12.2 Harbin Pharmaceutical Group Business Overview
- 8.12.3 Harbin Pharmaceutical Group Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Harbin Pharmaceutical Group Cinnarizine Tablets Product Portfolio
- 8.12.5 Harbin Pharmaceutical Group Recent Developments
- 8.13 Nanjing Baijingyu Pharmaceutical
- 8.13.1 Nanjing Baijingyu Pharmaceutical Company Information
- 8.13.2 Nanjing Baijingyu Pharmaceutical Business Overview
- 8.13.3 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Product Portfolio
- 8.13.5 Nanjing Baijingyu Pharmaceutical Recent Developments
- 8.14 Shanghai Xinyi Wanxiang Pharmaceutical
- 8.14.1 Shanghai Xinyi Wanxiang Pharmaceutical Company Information
- 8.14.2 Shanghai Xinyi Wanxiang Pharmaceutical Business Overview
- 8.14.3 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Product Portfolio
- 8.14.5 Shanghai Xinyi Wanxiang Pharmaceutical Recent Developments
- 8.15 CSPC
- 8.15.1 CSPC Company Information
- 8.15.2 CSPC Business Overview
- 8.15.3 CSPC Cinnarizine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 CSPC Cinnarizine Tablets Product Portfolio
- 8.15.5 CSPC Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cinnarizine Tablets Value Chain Analysis
- 9.1.1 Cinnarizine Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cinnarizine Tablets Production Mode & Process
- 9.2 Cinnarizine Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cinnarizine Tablets Distributors
- 9.2.3 Cinnarizine Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst